申请人:VIRBAC
公开号:US10729701B2
公开(公告)日:2020-08-04
The invention relates to compounds of formula (I), to the pharmaceutical compositions comprising same, and to the use thereof in the treatment of bacterial, fungal, viral and parasitic infections or in the treatment of cancer in humans or animals. In formula (I), R1 and R2 are as defined in claim 1.
本发明涉及式(I)化合物、包含式(I)化合物的药物组合物,以及将其用于治疗细菌、真菌、病毒和寄生虫感染或治疗人类或动物的癌症。在式 (I) 中,R1 和 R2 如权利要求 1 所定义。